Filing Details
- Accession Number:
- 0001104659-17-055904
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-06 22:12:59
- Reporting Period:
- 2017-09-01
- Accepted Time:
- 2017-09-06 21:12:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1491576 | Tesaro Inc. | TSRO | Pharmaceutical Preparations (2834) | 272249687 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1646675 | C. Grant Bogle | C/O Tesaro, Inc. 1000 Winter Street Waltham MA 02451 | Sr. Vp, Chief Commercial Ofc. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-09-01 | 8,333 | $59.71 | 11,543 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-09-01 | 2,917 | $43.39 | 14,460 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-09-01 | 14,167 | $135.00 | 293 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-09-01 | 8,333 | $0.00 | 8,333 | $59.71 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-09-01 | 2,917 | $0.00 | 2,917 | $43.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 66,667 | 2025-07-13 | No | 4 | M | Direct | |
| 32,083 | 2026-03-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Includes 55 shares purchased pursuant to the TESARO, Inc. 2012 Employee Stock Purchase Plan in transactions that were exempt under Section 16b-3(c) and Section 16b3-(d).
- The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $135.00 to $135.11, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- A quarter of the original grant of options to purchase 75,000 shares of common stock vested on July 13, 2016 and, thereafter, 1/36th of the remaining options vest on each monthly anniversary of such date until fully vested.
- The option to purchase 35,000 shares of common stock vests in 48 equal monthly installments beginning on April 1, 2016.
Billionaire Hedge Funds
